After scouring 200 companies’ pipelines — including a few overlooked pharma shelves — a new company backed by investment firm Population Health Partners and ARCH Venture Partners is launching with one of the most wide-ranging pipelines yet for obesity drug development.
Metsera came out of stealth mode Thursday with $290 million in seed and Series A financing. ARCH and Population Health Partners, which launched in 2020 and has several veterans from Pfizer and The Medicines Company on its team, led the round. F-Prime Capital, GV, Mubadala Capital, Newpath Partners, and SoftBank Vision Fund 2 were also part of the financing.
Metsera has already put that money to work: The New York startup licensed several drug candidates from South Korean biotech D&D Pharmatech, according to Endpoints and Korea Biomedical Review. Altogether, the deal is worth more than 1 trillion Korean won, or $740 million, in licensing fees and milestone payments.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe
window.statGlobal.analytics.fbq = function( eventName, parameters ) {
jQuery.ajax( {
url: '/wp-json/stat-analytics/v1/facebook-pixel',
type: 'POST',
data: {
event_name: !eventName ? null : eventName,
parameters: !parameters ? {} : parameters,
source_url: window.location.href
},
success: function( data, textStatus, jqXHR ) {
//console.log( data );
},
error: function ( jqXHR, textStatus, errorThrown ) {
//console.log( jqXHR );
}
} );
};
jQuery( window ).on( 'load', function() {
if ( !window.bgmpGdpr || window.bgmpGdpr.isOptedOut() ) {
return;
}
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;
n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
document,'script','https://connect.facebook.net/en_US/fbevents.js');
fbq( 'init', '436331036555416' );
fbq( 'track', 'PageView' );
document.addEventListener( 'stat-hubspot-signup-subscribed', () => {
// Successful HubSpot newsletter signup AJAX form submission.
window.statGlobal.analytics.fbq( 'Lead' );
} );
window.statGlobal.analytics.fbq( 'ViewContent' );
} );